E-viri
Recenzirano
Odprti dostop
-
Chau, Nguyen Van Vinh; Ngoc, Nghiem My; Nguyet, Lam Anh; Quang, Vo Minh; Ny, Nguyen Thi Han; Khoa, Dao Bach; Phong, Nguyen Thanh; Toan, Le Mau; Hong, Nguyen Thi Thu; Tuyen, Nguyen Thi Kim; Phat, Voong Vinh; Nhu, Le Nguyen Truc; Truc, Nguyen Huynh Thanh; That, Bui Thi Ton; Thao, Huynh Phuong; Thao, Tran Nguyen Phuong; Vuong, Vo Trong; Tam, Tran Thi Thanh; Tai, Ngo Tan; Bao, Ho The; Nhung, Huynh Thi Kim; Minh, Nguyen Thi Ngoc; Tien, Nguyen Thi My; Huy, Nguy Cam; Choisy, Marc; Man, Dinh Nguyen Huy; Ty, Dinh Thi Bich; Anh, Nguyen To; Uyen, Le Thi Tam; Tu, Tran Nguyen Hoang; Yen, Lam Minh; Dung, Nguyen Thanh; Hung, Le Manh; Truong, Nguyen Thanh; Thanh, Tran Tan; Thwaites, Guy; Tan, Le Van
EClinicalMedicine, 11/2021, Letnik: 41Journal Article
Data on breakthrough SARS-CoV-2 Delta variant infections in vaccinated individuals are limited. We studied breakthrough infections among Oxford-AstraZeneca vaccinated healthcare workers in an infectious diseases hospital in Vietnam. We collected demographic and clinical data alongside serial PCR testing, measurement of SARS-CoV-2 antibodies, and viral whole-genome sequencing. Between 11th–25th June 2021 (7-8 weeks after the second dose), 69 staff tested positive for SARS-CoV-2. 62 participated in the study. Most were asymptomatic or mildly symptomatic and all recovered. Twenty-two complete-genome sequences were obtained; all were Delta variant and were phylogenetically distinct from contemporary viruses obtained from the community or from hospital patients admitted prior to the outbreak. Viral loads inferred from Ct values were 251 times higher than in cases infected with the original strain in March/April 2020. Median time from diagnosis to negative PCR was 21 days (range 8–33). Neutralizing antibodies (expressed as percentage of inhibition) measured after the second vaccine dose, or at diagnosis, were lower in cases than in uninfected, fully vaccinated controls (median (IQR): 69.4 (50.7-89.1) vs. 91.3 (79.6-94.9), p=0.005 and 59.4 (32.5-73.1) vs. 91.1 (77.3-94.2), p=0.043). There was no correlation between vaccine-induced neutralizing antibody levels and peak viral loads or the development of symptoms. Breakthrough Delta variant infections following Oxford-AstraZeneca vaccination may cause asymptomatic or mild disease, but are associated with high viral loads, prolonged PCR positivity and low levels of vaccine-induced neutralizing antibodies. Epidemiological and sequence data suggested ongoing transmission had occurred between fully vaccinated individuals. Wellcome and NIH/NIAID
Avtor
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|
Vir: Osebne bibliografije
in: SICRIS
To gradivo vam je dostopno v celotnem besedilu. Če kljub temu želite naročiti gradivo, kliknite gumb Nadaljuj.